These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6226845)

  • 1. [Study of the interaction between glibenclamide and zimelidine in acute and chronic administration].
    Oltmanns D; Schwab J
    Med Welt; 1983 Sep; 34(35):926-9. PubMed ID: 6226845
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical studies of the interaction between tolmetin and glibenclamide.
    Chlud K; Kaik B
    Int J Clin Pharmacol Biopharm; 1977 Sep; 15(9):409-10. PubMed ID: 410740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Initial results in the treatment of diabetes mellitus with an association of glibenclamide and phenformin].
    Carta Q; Pugliese F
    Minerva Med; 1974 Jan; 65(1):27-57. PubMed ID: 4214410
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical experience with glibenclamide in long-term treatment of diabetes mellitus.
    Bandisode MS; Boshell BR
    Curr Ther Res Clin Exp; 1976 Feb; 19(2):237-41. PubMed ID: 813962
    [No Abstract]   [Full Text] [Related]  

  • 5. [Behavior of blood sugar and insulin in diabetics at the suspension of glibenclamide therapy].
    Pitucco G; Caputo V; Santucci A; Daniele E; De Mattia G; De Angelis A
    Clin Ter; 1978 Jun; 85(6):550-8. PubMed ID: 97042
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of glibenclamide in different forms of diabetes mellitus].
    Vasiukova EA; Pisarskaia IV; Granovskaia-Tsvetkova AM; Sharova IuA
    Sov Med; 1973 Dec; 36(12):56-9. PubMed ID: 4205164
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of glibenclamide on the glucose and insulin profile in maturity onset diabetics following both acute and long term treatment.
    Owens DR; Biggs PI; Shetty KJ; Wragg KG
    Diabete Metab; 1980 Sep; 6(3):219-24. PubMed ID: 6777211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Glibenclamide in type II diabetes as compared with placebo].
    Breier C; Lisch HJ; Drexel H; Sailer S
    Wien Klin Wochenschr; 1983 Mar; 95(6):200-3. PubMed ID: 6410589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interaction of sulfinpyrazone (Anturan) and glibenclamide (Euglucon) in type II diabetic patients].
    Kritz H; Najemnik C; Irsigler K
    Wien Med Wochenschr; 1983 May; 133(9):237-43. PubMed ID: 6408808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The glibenclamide-phenformin combination in the therapy of diabetes mellitus].
    Postiglione F; Verdoliva A; Schiraldi F
    Clin Ter; 1974 Jul; 70(2):147-51. PubMed ID: 4212848
    [No Abstract]   [Full Text] [Related]  

  • 11. [1-year study on the effect of guar on carbohydrate and lipid metabolism as well as tolerability in ambulatory glibenclamide-treated patients with diabetes mellitus].
    Klimm HD; Vollmar J; Bräuning C
    Beitr Infusionther Klin Ernahr; 1983; 12():206-15. PubMed ID: 6316912
    [No Abstract]   [Full Text] [Related]  

  • 12. Glibenclamide, acute/long-term response in M.O. diabetics.
    Owens DR; Wragg KG; Shetty KT; Biggs PI; Davies CD
    Horm Metab Res; 1979 Jun; 11(6):411-2. PubMed ID: 112018
    [No Abstract]   [Full Text] [Related]  

  • 13. [Modern oral sugar-reducing drugs: focus to glibenclamide].
    Ushakova EA
    Ter Arkh; 2007; 79(12):86-90. PubMed ID: 18220041
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical evaluation of glibenclamide in the treatment of diabetes mellitus].
    de Pupo AA; da Rocha DM
    Rev Paul Med; 1971 Jun; 77(6):247-50. PubMed ID: 5006000
    [No Abstract]   [Full Text] [Related]  

  • 15. Diurnal pattern of plasma insulin and blood glucose during glibenclamide and glipizide therapy in elderly diabetics.
    Groop L; Harno K
    Acta Endocrinol Suppl (Copenh); 1980; 239():44-52. PubMed ID: 6776763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Glibenclamide-insulin combination in the management of secondary failure of sulfonyl-urea medication].
    Hamelbeck H; Klein W; Zoltobrocki M; Schöffling K
    Dtsch Med Wochenschr; 1982 Oct; 107(42):1581-3. PubMed ID: 6813094
    [No Abstract]   [Full Text] [Related]  

  • 17. [Glibenclamide--a better antidiabetic agent?].
    Blohmé G
    Lakartidningen; 1972 Dec; 69(52):6147-9. PubMed ID: 4631025
    [No Abstract]   [Full Text] [Related]  

  • 18. [Practical viewpoints on the treatment of diabetes with glibenclamide].
    Wadman B; Werner I
    Lakartidningen; 1972 Sep; 69(37):4084-6. PubMed ID: 4627109
    [No Abstract]   [Full Text] [Related]  

  • 19. [Own observations on the action of glibenclamide (Daonil) in diabetes].
    Lopatyński J; Hanzlik J; Fijalkowska A
    Wiad Lek; 1974 Sep; 27(16):1465-70. PubMed ID: 4212730
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of multiple oral dosing of nimodipine on glibenclamide pharmacodynamics and pharmacokinetics in elderly patients with type-2 diabetes mellitus.
    Mück W; Heine PR; Breuel HP; Niklaus H; Horkulak J; Ahr G
    Int J Clin Pharmacol Ther; 1995 Feb; 33(2):89-94. PubMed ID: 7757317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.